Andrew Beggs is a Professor of Cancer Genetics & Surgery in the Department of Cancer and Genomic Sciences, University of Birmingham. He is also the Deputy Director of the Birmingham Experimental Cancer Medicine Centre and Theme Lead for Biomarkers and Liquid Biopsy. He also is Head of Somatic Cancer in the Central and South Genomic Medicine Service Alliance. He is a fellow of the Alan Turing Institute and has recently been awarded an MRC Senior Clinical Fellowship.
Why is there a rise in young people getting cancer?
National Study Day Speakers Comments
Faecal Microbiota Transplantation
Bowel Cancer: What is new and what is coming next?
COVID-19: Developing future testing strategies as the pandemic continues
Whole Genome Sequencing in the Fight Against COVID-19
Birmingham in Cancer Wards: Andrew Beggs’ Bowel Cancer Research
Genomics Birmingham offers expert genomic, transcriptomic, and epigenetic services, alongside a Technology Suite for researchers.
Our facilities, established in 2016, support experimental design and processing. We welcome collaborations with University of Birmingham researchers and external partners.
• Clinical grade whole genome and transcriptome sequencing of challenging clinical & environmental samples using short and long read sequencing
• Plasma, urine and body fluid sequencing using our proprietary nanopore cfDNA assay
• GI tract metagenomics & metatranscriptomics
• All Nanopore sequencing assays, pan species